Ledger.Open graph →
SEC Form D · filed September 1, 2021

PharmaCyte Biotech, Inc

Offering
$70.0M
Sold
$70.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LAGUNA HILLS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Thomas C. Yuen · Santa Ana, CADirectorMichael M. Abecassis · Laguna Hills, CADirectorCarlos A. Trujillo · Laguna Hills, CAExec · DirectorKenneth L. Waggoner · SILVER SPRING, MDExec · DirectorCrabtree W. Crabtree · Laguna Hills, CAExec · DirectorRaymond C. Tong · Laguna Hills, CADirectorThomas C. Liquard · Laguna Hills, CADirectorKenneth L. Waggoner · Laguna Hills, CAExec · DirectorThomas C. Yuen · Santa Ana, CADirectorCrabtree W. Crabtree · Laguna Hills, CAExec · DirectorMichael M. Abecassis · Laguna Hills, CADirectorRaymond C. Tong · Laguna Hills, CADirectorThomas C. Liquard · Laguna Hills, CADirectorCarlos A. Trujillo · Laguna Hills, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗